Receiver operating characteristic (ROC) curve areas for VWF and CD163 in relation to poor prognosis in AIS patients 90 days after RS implantation was 0.7256 (95% CI: 0.5630–0.8870) and 0.7639 (95% CI: 0.6163–0.9115), respectively. Here, CD163 is linked to androgen insensitivity syndrome.